Death receptor 5 agonistic antibody PRO95780: preclinical pharmacokinetics and concentration–effect relationship support clinical dose and regimen selection - Concepedia

Concepedia

Publication | Closed Access

Death receptor 5 agonistic antibody PRO95780: preclinical pharmacokinetics and concentration–effect relationship support clinical dose and regimen selection

11

Citations

28

References

2013

Year

Hong Xiang, Arthur E. Reyes, Steve Eppler, Sean K. Kelley, Lisa A. Damico‐Beyer

Cancer Chemotherapy and Pharmacology

ImmunologyPharmacologyClinical TrialsRegimen SelectionTherapeutic EfficacyClinical PharmacologyPharmacotherapyAgonistic Antibody Pro95780ImmunotherapyMedicinePharmacokineticsDeath Receptor 5

References

	Year	Citations

Page 1